Improving motor performance through visual rehabilitation

Analysis of Motor Performance Improvement Following Visual Rehabilitation Treatment in Individuals with Visual Field Defects Due to Acquired Brain Injury

NA · Instituto de Investigación Sanitaria Aragón · NCT06698172

This study is testing a virtual reality program to see if it can help adults with brain injuries improve their balance and movement by using special visual exercises.

Quick facts

PhaseNA
Study typeInterventional
Enrollment30 (estimated)
Ages18 Years to 80 Years
SexAll
SponsorInstituto de Investigación Sanitaria Aragón (other)
Locations2 sites (Zaragoza, Zaragoza and 1 other locations)
Trial IDNCT06698172 on ClinicalTrials.gov

What this trial studies

This study focuses on enhancing motor performance in adults with acquired brain injuries by utilizing a virtual reality rehabilitation program. The approach involves an interdisciplinary strategy that combines visual rehabilitation techniques, including the use of prisms and compensatory therapies, to address visual field loss and related motor difficulties. Participants will engage in exercises designed to stimulate brain plasticity and improve visual function, which is crucial for daily activities. The study aims to evaluate the effectiveness of these interventions in improving balance and overall motor performance.

Who should consider this trial

Good fit: Ideal candidates include adults with acquired brain injuries from strokes or trauma, who have specific visual field deficits and no cognitive impairments.

Not a fit: Patients with uncontrolled epilepsy, severe mental pathologies, or significant ocular conditions like glaucoma may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could significantly enhance the quality of life for patients with visual field loss and motor performance issues following brain injuries.

How similar studies have performed: While visual rehabilitation is more common in other countries, this specific approach using virtual reality is relatively novel and has shown promising results in preliminary evaluations.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult subjects diagnosed with acquired brain injury either from a stroke or trauma.
* Subjects without cognitive impairment.
* Subjects without pre-existing musculoskeletal disorders prior to the acquired brain injury.
* Subjects without hemineglect.
* Subjects with more than 6 months of progression since the brain injury.
* Subjects who have an electronic device such as a computer and internet access to perform the exercises at home.
* Subjects with altitudinal visual field loss, hemianopia, or quadrantanopia with the central field preserved and at least 0.5 visual acuity.

Exclusion Criteria:

* Not signing the informed consent.
* Previous severe mental pathology to eliminate possible confounding factors if their daily activities are already affected.
* Uncontrolled epilepsy.
* Subjects with glaucoma or retinal pathologies affecting the visual field.
* Subjects with previous ocular surgery (cataract or refractive surgery) with less than 6 months of progression.
* Subjects who are not stable in any associated clinical pathology or otherwise diagnosed.
* Subjects who have previously undergone visual rehabilitation for the field defect.
* Not performing the proposed home exercises.

Where this trial is running

Zaragoza, Zaragoza and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Visual Field Loss, Balance, Brain Injury, Motor Performance

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.